384 results on '"Bowman, W Paul"'
Search Results
2. Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
3. Outcomes in patients with ETV6::RUNX1or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
4. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
5. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
6. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.
7. Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations
8. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells
9. Universal cholesterol screening of children in community-based ambulatory pediatric clinics
10. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity
11. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study
12. Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL)
13. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia
14. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia
15. HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies
16. Early Nutrition Intervention Attenuates Weight Gain for Pediatric Acute Lymphoblastic Leukemia Patients in Maintenance Therapy
17. Rare Deleterious TCF3 Germline Variants and Predisposition to Acute Lymphoblastic Leukemia in Children
18. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
19. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
20. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
21. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
22. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
23. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
24. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
25. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
26. Childhood Cancer and Environmental Toxins: The Debate Continues
27. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
28. Identification of TCF3germline variants in pediatric B-cell acute lymphoblastic leukemia
29. Treating childhood acute lymphoblastic leukemia without cranial irradiation
30. Deletion on IKZF1 and prognosis in acute lymphoblastic leukemia
31. Mentors’ experiences in an osteopathic medical student research program
32. Association ofGATA3Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia
33. Overexpression of LLT1 (CLEC2D) in childhood Acute Lymphoblastic Leukemia (ALL)
34. Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics
35. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells
36. Abstract 2881: Antiproliferative effect of copper complex of clotam in neuroblastoma cell lines
37. Abstract 2605: Mithramycin enhances the efficacy of etoposide in Ewing sarcoma cells and a mouse xenograft tumor model
38. Educational attainment in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).
39. Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia
40. Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.
41. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia
42. Description of a multihospital process to develop a care path for the child with acute lymphoblastic leukemia
43. Abstract 889: Metformin treatment inhibits proliferation and induces apoptosis in medulloblastoma cells
44. Abstract 3188: Combination treatment strategies to enhance the effect of standard chemotherapeutic agents in Ewing sarcoma cells
45. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia
46. Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels
47. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
48. Poster 288: Simultaneous Bilateral Valgus Slipped Capital Femoral Epiphysis in an 11‐Year‐Old Girl: A Case Report
49. Abstract 1947: Combination of Vincristine and Clotam induces antiproliferative response in medulloblastoma cells
50. Abstract 1532: Mithramycin induces the antiproliferative activity of chemotherapeutic agents in Ewing sarcoma cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.